Distributive Justice and Infertility Treatment in Canada

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 5, 2008, Pages 425-431

  Nisker, Jeff ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Access to infertility treatment; Assisted reproduction; Distributive justice; Socioeconomic discrimination in health care

Indexed keywords

ALTRUISM; ARTICLE; BUDGET; CANADA; CRYOPRESERVATION; FERTILIZATION IN VITRO; FUNDING; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HUMAN; INFERTILITY THERAPY; LAW; MEDICAL DECISION MAKING; POPULATION RESEARCH; DECISION MAKING; ECONOMICS; ETHICS; FEMALE; INFERTILITY; REVIEW; THEORETICAL MODEL;

CANADA; DECISION MAKING; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFERTILITY; MODELS, THEORETICAL; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 48249132102     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32828-6     Document Type: Article

References (114)

1. Rawls J. A theory of justice 1971, Belknap Press of Harvard University, Cambridge, MA.
2. Beauchamp J.F., Childress T.L. Principles of biomedical ethics 1979, Oxford University Press, London.
3. Bourgeois W. Persons: what philosophers say about you 1995, 413-423. Wilfrid Laurier University Press, Waterloo.
4. Ellingsen T., Johannesson M. Does impartial deliberation breed fair behavior? An experimental test. Rationality and Society 2005, 17(1):116-136.
5. Bond D., Park J.-C. An empirical test of Rawls's theory of justice: a second approach, in Korea and the United States. Simulation & Gaming 1991, 22(4):443-462.
6. Canada. Assisted Human Reproduction Act, S.C. 2004, s. 40(3.1). Canada. An Act respecting assisted human reproduction and related research, Bill C-13. Available at: . Accessed November 6, 2003. http://www.parl.gc.ca/37/2/parlbus/chambus/house/bills/government/C-13/C-13_3/90187bE.html.
7. Sweden In Vitro Fertilisation Act 1988.
8. France Bioethics Law July 8, 1994, 94-654.
9. Germany Act for Protection of Embryos 2001, The Embryo Protection Act.
10. Australia Attorney General. Research Involving Human Embryos Act, 2002 Australia. Prohibition of Human Cloning Act 2002, 2002.
11. The Netherlands Act containing rules relating to the use of gametes and embryos (Embryos Act) Available at:, Accessed March 6, 2008. http://www.minvws.nl/images/eng-embryowettekst_tcm20-107819.pdf.
12. Norway. Law No. 56 of 1994 (on the Medical Use of Biotechnology), Chapter 3.
13. Israel In Vitro Fertilization Health Law 1987.
14. Belgium Loi relative a la recherche sur les embryons in vitro Available at:, Accessed March 6, 2008. http://www.ejustice.just.fgov.be/cgi/summary_body.pl?language=fr&pub_date=2003-05-28.
15. Mykitiuk R. Nisker J. Assisted reproduction. In: Singer PA, Viens AM, eds. Bioethics for clinicians. Cambridge: Cambridge University Press. In press.
16. Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update 2002, 8(3):265-277.
17. Canada Canadian Charter of Rights and Freedoms Available at:, Accessed Aug 9, 2007. http://laws.justice.gc.ca/en/Charter/index.html.
18. Egan v.Canada Available at:, Accessed March 6, 2008. http://scc.lexum.umontreal.ca/en/1995/1995rcs2-513/1995rcs2-513.html.
19. Royal Commission on New Reproductive Technologies Patricia Baird, Chair. Proceed With Care: Final Report of the Royal Commission on New Reproductive Technologies 1993, Minister of Supply and Services Canadian Government Publishing; Ottawa, Ottawa.
20. Haan G., van Steen R. Costs in relation to effects of in-vitro fertilization. Hum Reprod 1992, 7(7):982-986.
21. Mills M.S., Eddowes H.A., Cahill D.J., Fahy U.M., Abuzeid M.I., McDermott A., et al. A prospective controlled study of in-vitro fertilization, gamete intra-fallopian transfer and intrauterine insemination combined with superovulation. Hum Reprod 1992, 7:490-494.
22. Alsalili M., Yuzpe A., Tummon I., Parker J., Martin J., Daniel S., et al. Cumulative pregnancy rates and pregnancy outcome after in-vitro fertilization: > 5000 cycles at one centre. Hum Reprod 1995, 10:470-474.
23. Hughes E.G., Beecroft M.L., Wilkie V., Burville L., Claman P., Tummon I., et al. A multicentre randomized controlled trial of expectant management versus IVF in women with Fallopian tube patency. Hum Reprod 2004, 19:1105-1109.
24. Evans R; Commission on the Future of Healthcare in Canada. Raising the money: options, consequences, and objectives for financing health care in Canada [monograph on the Internet]. Oct 2002 [cited September17, 2007]; Discussion paper No. 27. Available at: pdf/romanow/pdfs/27_Evans_E2.pdf. Accessed March 6, 2008. http://www.hc-sc.gc.ca/english/.
25. Citizenship and Immigration Canada [news article on Internet] International adoptions. The Monitor [cited September 17, 2007]. Available at:, Accessed March 6, 2008. http://www.cic.gc.ca/english/resources/statistics/monitor/issue03/06-feature.asp.
26. Nisker J., Bergum V. A child on her mind. Motherlife: studies of mothering experience 2007, 358-398. Pedagon publishing, Edmonton. J. Nisker, V. Bergum (Eds.).
27. Bergum V. A child on her mind: the experience of becoming a mother 1997, Bergin & Garvey, London.
28. Hughes E.G., Giacomini M. Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics. Fertil Steril 2001, 76:431-442.
29. Dalton M., Lilford R.J. Benefits of in-vitro fertilization. Lancet 1989, 2:1327.
30. DeZoeten M.J., Tymstra T., Alberda A.T. The waiting list for IVF: the motivations and expectations of women waiting for treatment. Hum Reprod 1987, 2:623.
31. Ombelet W., De Sutter P., Van der Elst J., Martens G. Multiple gestation and infertility treatment: registration, reflection and reaction-the Belgian project. Hum Reprod Update 2005, 11:3-14.
32. Lukassen H., Schönbeck Y., Adang E., Braat D., Zielhuis G., Kremer J. Cost analysis of singleton versus twin pregnancies after in vitro fertilization. Fertil Steril 2004, 81:1240-1246.
33. Luke M., Brown P., Alexandre T., Kinoshi M., O'Sullivan D., Martin R., et al. The cost of twin pregnancy: maternal and neonatal factors. Am J Obstet Gynecol 2005, 192:909-915.
34. Barrett J., Bocking A. Management of twin pregnancies, part 2. SOGC Consensus Statement, No. 93, August 2000. J. Soc Obstet Gynecol Can 2000, 22:607-610.
35. Min J.K., Claman P., Hughes E. Guidelines for the number of embryos to transfer following in vitro fertilization. SOGC clinical Practice Guideline, N0.182, September 2006. J Obstet Gynaecol Can 2006, 28:799-813.
36. Phibbs C.S., Schmitt S.K. Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. Early Hum Dev 2006, 82:85-95.
37. Gilbert W.M., Nesbitt T.S., Danielsen B. The cost of prematurity: quantification by Gestational age and birth weight. Obstet Gynecol 2003, 102:488-492.
38. Stevenson R.C., McCabe C.J., Pharoah P.O.D., Cooke R.W.I. Cost of care for a geographically determined population of low birth weight infants to age 8-9 years: children without disability. Arch Disease Child 1996, 74:F114-F117.
39. Stevenson R.C., Pharoah P.O.D., Stevenson C.J., McCabe C.J., Cooke R.W.I. Cost of care for a geographically determined population of low birth weight infants to age 8-9 years: children with disability. Arch Disease Child 1996, 74:F118-F121.
40. Drack A.V. Preventing blindness in premature infants. New Engl J Med 1998, 338:1619-1621.
41. Elster N. Less is more: the risks of multiple births. Fertil Steril 2000, 74.
42. Adamson D., Baker V. Multiple births from assisted reproductive technologies: a challenge that must be met. Fertil Steril 2004, 81:500-504.
43. Inder T.E., Warfield S.K., Wang H., Hüppi P.S., Volpe J.J. Abnormal cerebral structure is present at term in premature infants. Pediatrics 2005, 115:286-294.
44. Fluker M.R., Tiffin G.J. Assisted reproductive technologies-a primer for Canadian physicians. J Soc Obstet Gynecol Can 1996, 18:451-465.
45. Schenker J.G., Shushan A. Ethical and legal aspects of assisted reproduction practice in Asia. Hum Reprod 1996, 11:908-911.
46. Granberg M., Wikland M., Hamberger L. Financing of IVF/ET in the Nordic countries. Acta Obstet Gynecol Scand 1998, 77:63-67.
47. Mantovani L.G., Belisari A., Szucs T.D. Pharmaco-economic aspects of in-vitro fertilization in Italy. Hum Reprod 1999, 14:953-958.
48. Goverde A.J., McDonnell J., Vermeiden J.P.W., Schats R. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility. Lancet 2000, 355(9197):13-18.
49. Philips Z., Barraza-Llorens M., Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod 2000, 15:95-106.
50. Smith JL. Australian Health Policy Institute Policy [monograph on Internet]. Medicare and Assisted Reproductive Technologies: Briefing Paper #1; May 2006 [cited September 17, 2007].
51. Collins J.A., Bustillo M., Visscher R.D., Lawrence L.D. An estimate of the cost of in vitro fertilization services in the United States in 1995. Fert Steril 1995, 64:538-545.
52. Neumann P.J., Weinstein M.C., Gharib S.D. The cost of a successful delivery with in vitro fertilization. N Engl J Med 1994, 331:239-243.
53. Bissonnette F. La procreation médicalement assistée au Canada et au Québec-Survol et enjeux 2006, Prepared for the Justice Department.
54. Claman P. The Assisted Human Reproduction Act. J Obstet Gynaecol Can 2007, 29:303-304.
55. Nisker J. Rachel's ladders or how societal situation determines reproductive therapy. Hum Reprod 1996, 11(6):1162-1167.
56. Nisker J. In quest of the perfect analogy for using in vitro fertilization patients as oocyte donors. Womens Health Issues 1997, 7:241-247.
57. Nisker J. Physician obligation in oocyte procurement. Am J Bioeth 2001, 1:22-23.
58. Nisker J. Response to Quebec challenge to the Assisted Human Reproduction Act, prepared for the Justice Department 2006.
59. Pastor C.L., Vanderhoof V.H., Lim L.C., Calis K.A., Premkumar A., Guerrero N.T., Nelson L.M. Pilot study investigating the age-related declinet in ovariantles-title function of regularly menstruating normal women. Fertil Steril 2005, 84:1462-1469.
60. Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 1999, 33:24-28.
61. Nisker J., Baylis F., McLeod C. Choice in fertility preservation in girls and adolescent women with cancer. Cancer 2006, 107(S7):1686-1689.
62. Anasti J.N. Premature ovarian failure: an update. Fertil Steril 1998, 70:1-15.
63. Laml T., Preyer O., Umek W., Hengstschlager M., Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update 2002, 8:483-491.
64. Goswami D., Conway D.S. Premature Ovarian Failure. Hum Rep Update 2005, 11:391-410.
65. Radio One C.B.C. Oh Baby!" May 2 2007.
66. Gurmankin A.D. Risk information provided to prospective oocyte donors in a preliminary phone call. Am J Bioethics 2001, 1:3-13.
67. Spar D. The egg trade-making sense of the market for human oocytes. N Engl J Med 2007, 356:1289-1291.
68. Magureanu G. Letter to European Parliament. June 2005, 30. Available at:, Accessed August 14, 2006. http://www.handsoffourovaries.com/pdfs/appenixg.pdf.
69. Sexton S. Transforming 'waste' into 'resource': from women's eggs to economics for women. Paper presented at Femme Globale Conference. Available at: . Accessed July 31, 2006. http://www.thecornerhouse.org.uk/pdf/document/eggs.pdf.
70. Beeson D., Lippman A. Egg harvesting for stem cell research: medical risks and ethical problems. Reprod Biomed Online 2006, 13:573-579.
71. Younis J.S., Ezra Y., Laufer N., Ohel G. Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata. J Assist Reprod Genet 1997, 14:343-346.
72. Miller P.B., Price T., Nichols J.E., Hill L. Acute ureteral obstruction following transvaginal oocyte retrieval for IVF: case report. Hum Reprod 2002, 17:137-138.
73. Mertes H., Pennings G. Oocyte donation for stem cell research. Hum Reprod 2007, 22:629-634.
74. Abramov Y., Elchalal U., Schenker J.G. An 'epidemic' of severe OHSS: a price we have to pay?. Hum Reprod 1999, 14:2181-2183.
75. George K. What about the women? Ethical and policy aspects of egg supply for cloning research. Reprod Biomed Online 2007, 15:127-133.
76. Practice Committee of the American Society for Reproductive Medicine Ovarian hyperstimulation syndrome. Fertil Steril 2003, 80:1309-1314.
77. Balen A. Ovarian hyperstimulation syndrome-A short report for the HFEA [monograph on the Internet] [cited September 17, 2007]. Available at:, Accessed March 10, 2008. http://www.hfea.gov.uk/docs/OHSS_Short_%20report_for_HFEA_by_Professor_%20Adam_Balen_General_Infirmary_Leeds_February_2005.pdf.
78. BBC News IVF treatment killed my daughter [cited September 17, 2007]. Available at:, Accessed June 5, 2007. http://news.bbc.co.uk/1/hi/health/4635261.stm.
79. BBC News 2005b UK woman killed by rare IVF risk [cited September 17, 2007]. Available at:, Accessed June 5, 2007. http://news.bbc.co.uk/1/hi/health/4440573.stm.
80. Shatford L., Brown S., Yuzpe A.A., Nisker J.A., Casper R.F. The assessment of experienced pain associated with transvaginal ultrasound guided oocyte recovery in IVF patients. Am J Obstet Gynecol 1989, 160:1002-1006.
81. Newton C.R., Hearn M.T., Yuzpe A.A. Psychological assessment and follow-up after in vitro fertilization: assessing the impact of failure. Fertil Steril 1990, 54:879-886.
82. Boivin J., Scanlan L.C., Walker S.M. Why are infertile patients not using psychosocial counselling?. Hum Reprod 1999, 14:1384-1391.
83. Conklin J. Giving the greatest gift of all: Infertile couples find hope in UW's egg donor program. The Online Daily of the University of Washington. January 1996, 16.
84. Fielding D., Handley S., Duqueno L., Weaver S., Lui S. Motivation, attitudes and experience of donation: a follow-up of women donating eggs in assisted conception treatment. J Community Appl Soc Psychol 1998, 8:273-287.
85. Randal A.E. The personal, interpersonal, and political issues of egg donation. J Obstet Gynaecol Can 2004, 26:1087-1090.
86. Yee S., Hitkari J.A., Greenblatt E.M. A follow-up study of women who donated oocytes to known recipient couples for altruistic reasons. Hum Reprod 2007, 22:2040-2050.
87. Ahuja K.K., Simons E.G., Edwards R.G. Money, morals and medical risks: conflicting notions underlying the recruitment of egg donors. Hum Reprod 1999, 14:279-284.
88. Safeguards for donors [editorial]. Nature 2006, 442:601.
89. Daniels N. Democratic equality: Rawls's complex egalitarianism. Cambridge Companion to Rawls 2003, Cambridge University Press, London. S. Freeman (Ed.).
90. Balen A.H., Jacobs H.S. Infertility in practice 2003, Churchill Livingston London, London. 2nd ed.
91. Frank A.W. The renewal of generosity: illness, medicine, and how to live 2004, The University of Chicago Press, Chicago.
92. Nisker J., The White A.D., CMA Code of Ethics and the donation of fresh embryos for stem cell research. CMAJ 2005, 173:621-622.
93. Fehr E., Fischbacher U. The nature of human altruism. Nature 2003, 425:785-791.
94. Noonan J. Between egoism and altruism: outlines for a materialist conception of the good. Critical Review of International Social and Political Philosophy 2002, 5:68-86.
95. Dawkins R. The selfish gene: 30th anniversary edition 2006, Oxford University Press, London.
96. Austria The Law on Medically Assisted Human Reproduction 1992.
97. Marshall L.A. Intergenerational gamete donation: Ethical and societal implications. Am J Obstet Gynecol 1998, 178:1171-1176.
98. Frith L. Gamete donation and anonymity: The ethical and legal debate. Hum Reprod 2001, 16:818-824.
99. Blyth E. Patient experiences of an "egg sharing" programme. Hum Fertil 2004, 7:157-162.
100. Delmonico F.L., Arnold R., Scheper-Hughes N., Siminoff L.A., Khn J., Youngner S.J. Ethical incentives-not payment-for organ donation. N Eng J Med 2002, 346:2002-2005.
101. Kondro W. Debate over online recruitment of organ donors. CMAJ 2005, 172:165-166.
102. Hanto D.W. Ethical challenges posed by the solicitation of deceased and living organ donors. N Eng J Med 2005, 356:1062-1066.
103. Kingdom United Regulation of research on human embryos 1990, Human Fertilisation and Embryology Authority.
104. Gorrill M.J., Johnson L.K., Patton P.E., Burry K.A. Oocyte donor screening: the selection process and cost analysis. Fertil Steril 2001, 75:400-404.
105. Murray C., Golombok S. Oocyte and semen donation: a survey of UK licensed centres. Hum Reprod 2000, 15:2133-2139.
106. Marina S., Exposito R., Marina F., Nadal J., Masramon M., Verges A. Oocyte donor selection from 554 candidates. Hum Reprod 1999, 14:2770-2776.
107. Söderström-Anttila V. Follow-up study of Finnish volunteer oocyte donors concerning their attitudes to oocyte donation. Hum Reprod 1995, 10:3073-3076.
108. Kan A.K.S., Abdalla H.I., Ogunyemi B.O., Korea L., Latarche E. A survey of anonymous oocyte donors: demographics. Hum Reprod 1998, 13:2762-2766.
109. Lornage J., Chorier H., Boulieu D., Mathieu C., Czyba J.C. Six year follow-up of cryopreserved embryos. Hum Reprod 1995, 10:2610-2612.
110. Van Voorhuis B.J., Grinstead D.M., Sparks A.E.T., Gerard J.L., Weir R.F. Establishment of a successful donor embryo program: medical, ethical, and policy issues. Fertil Steril 1999, 71:604-608.
111. Soderstrom-Anttila V., Foudila T., Ulla-Riitta R., Siegberg R. Embryo donation: outcome and attitudes among embryo donors and recipients. Hum Reprod 2001, 16:1120-1128.
112. Newton C.R., McDermid A., Tekpetey F., Tummon I.S. Embryo donation: attitudes toward donation procedures and factors predicting willingness to donate. Hum Reprod 2003, 18:878-884.
113. Nisker J., White A., Tekpetey F., Feyles V. Development and investigation of a free and informed choice process for embryo donation to stem cell research in Canada. J Obstet Gynaecol Can 2006, 28:903-908.
114. Saunders D.M., Garner F. Oocyte donation using "known" donors: it may seem the convenient answer but who pays?. Hum Reprod 1996, 11:2356-2357.